Redman BG - Search Results

1

A phase I-II study of dacarbazine in combination with outpatient interleukin-2 in metastatic malignant melanoma.

Flaherty LE, Redman BG, Chabot GG, Martino S, Gualdoni SM, Heilbrun LK, Valdivieso M, Bradley EC. Flaherty LE, et al. Among authors: redman bg. Cancer. 1990 Jun 1;65(11):2471-7. doi: 10.1002/1097-0142(19900601)65:11<2471::aid-cncr2820651113>3.0.co;2-f. Cancer. 1990. PMID: 2337862

2

Phase 2 study of RO4929097, a gamma-secretase inhibitor, in metastatic melanoma: SWOG 0933.

Lee SM, Moon J, Redman BG, Chidiac T, Flaherty LE, Zha Y, Othus M, Ribas A, Sondak VK, Gajewski TF, Margolin KA. Lee SM, et al. Among authors: redman bg. Cancer. 2015 Feb 1;121(3):432-440. doi: 10.1002/cncr.29055. Epub 2014 Sep 23. Cancer. 2015. PMID: 25250858 Free PMC article. Clinical Trial.

3

5-Fluorouracil, etoposide, and cisplatin in the management of metastatic non-small cell lung cancer.

Flaherty L, Wozniak A, Redman B, Kraut M, Martino S, Heilbrun L, Valdivieso M. Flaherty L, et al. Cancer. 1991 Sep 1;68(5):944-7. doi: 10.1002/1097-0142(19910901)68:5<944::aid-cncr2820680506>3.0.co;2-g. Cancer. 1991. PMID: 1655218 Clinical Trial.

4

Phase II study of deoxydoxorubicin in previously untreated metastatic breast cancer.

Martino S, Samal BA, Redman B, Flaherty L, Kraut M, Simon M, Valdivieso M. Martino S, et al. Breast Cancer Res Treat. 1990 Dec;17(2):139-43. doi: 10.1007/BF01806294. Breast Cancer Res Treat. 1990. PMID: 2096991 Clinical Trial.

5

Weekly 1-hour infusion of paclitaxel. Clinical feasibility and efficacy in patients with hormone-refractory prostate carcinoma.

Trivedi C, Redman B, Flaherty LE, Kucuk O, Du W, Heilbrun LK, Hussain M. Trivedi C, et al. Cancer. 2000 Jul 15;89(2):431-6. doi: 10.1002/1097-0142(20000715)89:2<431::aid-cncr31>3.0.co;2-b. Cancer. 2000. PMID: 10918176 Clinical Trial.

6

Phase I trial of recombinant macrophage colony-stimulating factor by rapid intravenous infusion in patients with cancer.

Redman BG, Flaherty L, Chou TH, Kraut M, Martino S, Simon M, Valdivieso M, Groves E. Redman BG, et al. J Immunother (1991). 1992 Jul;12(1):50-4. doi: 10.1097/00002371-199207000-00006. J Immunother (1991). 1992. PMID: 1637782 Clinical Trial.

7

Sequential dacarbazine/cisplatin and interleukin-2 in metastatic melanoma: immunological effects of therapy.

Redman BG, Flaherty L, Chou TH, Nakeff A, Pillote K, Kaplan J. Redman BG, et al. J Immunother (1991). 1991 Apr;10(2):147-51. doi: 10.1097/00002371-199104000-00009. J Immunother (1991). 1991. PMID: 2043595

8

A phase I trial of recombinant interleukin-2 combined with recombinant interferon-gamma in patients with cancer.

Redman BG, Flaherty L, Chou TH, al-Katib A, Kraut M, Martino S, Chen B, Kaplan J, Valdivieso M. Redman BG, et al. J Clin Oncol. 1990 Jul;8(7):1269-76. doi: 10.1200/JCO.1990.8.7.1269. J Clin Oncol. 1990. PMID: 2113571

9

Case report: development of Hodgkin's disease in patient receiving long-term administration of dacarbazine and interleukin-2 for metastatic melanoma.

Flaherty LE, Schwert R, Redman BG. Flaherty LE, et al. Among authors: redman bg. J Natl Cancer Inst. 1990 Aug 15;82(16):1360. doi: 10.1093/jnci/82.16.1360. J Natl Cancer Inst. 1990. PMID: 2380992 No abstract available.

10

Antitumor efficacy of interleukin-2 alone and in combination with adriamycin and dacarbazine in murine solid tumor systems.

LoRusso PM, Aukerman SL, Polin L, Redman BG, Valdivieso M, Biernat L, Corbett TH. LoRusso PM, et al. Among authors: redman bg. Cancer Res. 1990 Sep 15;50(18):5876-82. Cancer Res. 1990. PMID: 2393858

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

109 results

Search Page

Filters